Treatt PLC
LSE:TET
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Treatt PLC
Cash & Cash Equivalents
Treatt PLC
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Treatt PLC
LSE:TET
|
Cash & Cash Equivalents
ÂŁ1.8m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
14%
|
|
Johnson Matthey PLC
LSE:JMAT
|
Cash & Cash Equivalents
ÂŁ542m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
Croda International PLC
LSE:CRDA
|
Cash & Cash Equivalents
ÂŁ172.5m
|
CAGR 3-Years
17%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
Victrex PLC
LSE:VCT
|
Cash & Cash Equivalents
ÂŁ28.5m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-10%
|
|
Elementis PLC
LSE:ELM
|
Cash & Cash Equivalents
$65.8m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
0%
|
|
Synthomer PLC
LSE:SYNT
|
Cash & Cash Equivalents
ÂŁ371.3m
|
CAGR 3-Years
23%
|
CAGR 5-Years
31%
|
CAGR 10-Years
20%
|
See Also
What is Treatt PLC's Cash & Cash Equivalents?
Cash & Cash Equivalents
1.8m
GBP
Based on the financial report for Mar 31, 2024, Treatt PLC's Cash & Cash Equivalents amounts to 1.8m GBP.
What is Treatt PLC's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
14%
Over the last year, the Cash & Cash Equivalents growth was -28%. The average annual Cash & Cash Equivalents growth rates for Treatt PLC have been -40% over the past three years , -45% over the past five years , and 14% over the past ten years .